Strata Critical Medical saw revenue jump 36.7% year-over-year to $49.3 million in Q3 2025. However, net loss widened to $9.7 million due to increased legal and investment-related expenses. Flight profit and margins improved, and the company posted record Medical Segment Adjusted EBITDA.
Revenue rose 36.7% YoY to $49.3 million, driven by Air and Ground Logistics growth.
Net loss widened to $9.7 million, largely due to legal reserves and realized investment losses.
Adjusted EBITDA surged to $4.2 million, up from $67K a year ago.
Medical Segment Adjusted EBITDA reached $7.6 million, with a margin of 15.3%.
Strata raised its 2025 revenue guidance and reaffirmed Adjusted EBITDA expectations, supported by strong organic growth and the integration of Keystone Perfusion.
Analyze how earnings announcements historically affect stock price performance